Thank you for contacting ReportLinker and submitting your question. From the many reports available to ReportLinker, we have selected three about the antidepressant market in the US and one about the global market. We hope that this helps answer your question.
The first report, United States Antidepressant Industry 2015 Market Research Report was published by QY Research Group in August 2015. The 236 page study provides an overview of the industry, including definitions, classifications, applications and industry chain structure. The US market analysis looks at trends, the competitive landscape, development policies, plans, manufacturing processes, imports and exports, supply and demand, cost, price, revenue and gross margins. It looks at the key players, their product specifications, costs, revenues and other details. It also looks at the feasibility of new investments and provides key tables and statistics.
The second report, titled Antidepressant Market in the US 2015-2019 was published by Infinitil Research Limited in January 2015. The 104 page report forecasts the US market to grow at a compound annual growth rate of 4.08% from 2014-2019. It looks at the current situation of the market, analyzing the market size, market segments, drivers, trends and challenges. The key players are Actavis, Eli Lilly and Company, GlaxoSmithKline, Otsuka Pharmaceutical and Pfizer. The market is segmented into tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors and others.
The third report is called Antidepressants (Migraine) – Forecast and Market Analysis to 2023 and it was published by Global Data in March 2014. The 42 page study investigates the market for antidepressants in the treatment of migraines. It features an overview of migraines, information on antidepressants, a SWOT analysis and sales forecasts from 2012-2023 for the US, France, Italy, Spain and Japan. It looks at the changing competitive market for migraines, and helps to identify which products are most likely to ensure a strong return. By 2023, the migraine market is expected to be valued at $3.7 billion, with a compound annual growth rate of 3.6%.
The final report, The 2016-2021 World Outlook for Psychotherapeutic Antidepressant Agents was published in April 2015 by ICON Group. The 244 page report features a global outlook for psychotherapeutic antidepressant agents. It gives estimates on the latent demand, potential industry earnings and market share for most of the countries in the world. It is a strategic paper, with an aggregate, long-run view and thus it does not include specific players, specific product details or short-term cyclicality.
We hope this information has been helpful to you. There is a lot of useful information about the antidepressant market in ReportLinker’s portal. If you have any questions or any further needs, please feel free to contact us.